麦克森 (MCK)_个股概要_股票价格_行情走势图

自选
模拟交易
选股器
热力图
机构追踪

美股市场个股详情

MCK 麦克森

添加自选

532.715
+5.395+1.02%

交易中 04/23 14:25 (美东)

700.03亿总市值24.08市盈率TTM

盘中分时

5日
日K
周K
月K
季K
年K

资金分布

单位: --

资金流向

实时日周月

暂无数据

新闻

高盛的回购篮子：2024年回购增长将达到13％
高盛分析师重新平衡了 “回购篮子”，预计2024年的回购增长为13％。
Seeking Alpha04/22 13:23 (美东)
买入评级得到确认：OptumRx合约获胜推动了麦克森的战略增长
TipRanks04/22 12:15 (美东)
快讯 | 麦克森公司股价上涨约1％
Moomoo 24/704/22 09:35 (美东)
快讯 | Evercore表示麦克森将从7月开始赢得OptumRx合同
Moomoo 24/704/22 09:18 (美东)
为什么麦克森（MCK）是长期价值最高的股票
Yahoo Finance04/19 09:40 (美东)
吉姆·克莱默 “愿意让这只制药股着火”，建议不要出售麦克森
在CNBC的 “Mad Money Lightning Round” 中，吉姆·克莱默建议持有康菲石油公司（纽约证券交易所代码：COP）Rhythm Pharmicals, Inc.（纳斯达克股票代码：RYTM）是 “投机游戏”，“我不反对 specul
Benzinga04/19 08:46 (美东)

Moomoo AI

02/14 20:10

McKesson's statutory earnings may not reflect its true productivity due to a large unusual item. Its real earnings power could be less than its statutory profit. Investors should understand the risks, including the identified warning sign with McKesson, before investing.

McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues

Moomoo AI

02/07 03:22

Despite McKesson's EPS growth, market sentiment appears pessimistic. Improved shareholder return suggests business improvement, yet McKesson may not be the best stock to buy, with one warning sign to note.

McKesson's (NYSE:MCK) 32% CAGR Outpaced the Company's Earnings Growth Over the Same Five-year Period

Moomoo AI

2023/12/27 01:38

Despite its weaker earnings outlook and slower expected growth, McKesson is trading at a similar P/E to the market, possibly setting investors up for future disappointment if the P/E aligns more with the growth outlook.